Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
Review Erowid at
Help us be a 2021 "Top Rated Nonprofit", and spread accurate info
about psychoactive drugs, health, culture, & policies.
("Share Your Story" link. Needs quick account creation but doesn't verify contact info)
cover image
Psychedelic Drugs Reconsidered
A Drug Policy Classic Reprint from the Lindesmith Center
Rating :
Author(s) :
Lester Grinspoon
James B. Bakalar
Pages :
Pub Date :
June 1997
Edition(s) at Erowid :
Publisher :
The Lindesmith Center
401 Unauthorized


This server could not verify that you are authorized to access the document requested. Either you supplied the wrong credentials (e.g., bad password), or your browser doesn't understand how to supply the credentials required.

Two of the world's leading experts on drug use provide the general reader with a comprehensive survey of psychedelic drugs and the scientific and intellectual issues they raise. The authors review the chemistry of psychedelics, their effects, and the history of human experience with them as well as assessing the potential value of the drugs.

"An exceptionally well-balanced scientific discussion of every aspect of psychedelic drugs . . . It is a courageous book which simultaneously succeeds both for the popular and scientific audiences."
-- Carl Sagan

"Our social policy has all but ignored the extraordinary potential of psychedelic drugs for therapeutic use and inner development. This book has played and will continue to play a significant role in bringing the weight of scientific reason to bear on re-opening the research opportunities that are a necessary prerequisite for rectifying this situation."
-- Ram Dass

"I don't recall ever seeing a single book treat in so scholarly yet lucid a fashion all the historical, social, and scientific aspects of drugs with accuracy, balance, and throughtful reflection."
-- Solomon H. Snyder, M.D.

Lester Grinspoon, M.D. is an associate professor of psychiatry at Harvard Medical School

James B. Bakalar is a lecturer in law in the Department of Psychiatry at Harvard Medical School.